Beam Therapeutics advances base-editing pipeline with risto-cel studies and FDA designations, but no approved products and rising competition loom.

On the final trading day of 2025, Cathie Wood put an eye-brow raising $1.33 million to work in Intellia Therapeutics ( NTLA ) ...

Blockchain, nanomedicine, and 3D printing signal a growing emphasis on improving healthcare delivery through innovative ...

In one of the rockiest years yet for science, Philadelphia-area researchers still managed to celebrate many wins. Here are five of them.

Sana Biotechnology Inc. (NASDAQ:SANA) is one of the best emerging technology stocks to invest in. On December 8, Sana ...

After years of research, scientists in China have created a bone-free fish, which has been named 'Zhongke No. 6'. The new ...

India's first gene-edited sheep recently turned a year old and researchers who developed it say it's doing well. Born on 16 ...

Prime Medicine Inc. (NASDAQ:PRME) is one of the best biotech penny stocks to buy according to analysts. On December 23, LifeSci Capital initiated coverage of Prime Medicine with an Outperform rating ...

Gene editing has moved from theory to bedside with a speed that would have seemed impossible a decade ago. A new wave of ...

Matthew Herper covers medical innovation — both its promise and its perils. It has been a tough year for medicine. The U.S.

The EPA is the authority charged with regulating biosafety and genome editing. Its tasks include granting permits, conducting risk assessments, and overseeing compliance. On the other hand, the Bio ...

Two genetic innovations could address major welfare and productivity issues within the broiler and layer industries.